Drug Patents owned by Zealand Pharma
1. List of Zegalogue drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10442847 | ZEALAND PHARMA | Glucagon analogues |
Feb, 2035
(11 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity (NCE) | Mar 22, 2026 |
Drugs and Companies using DASIGLUCAGON HYDROCHLORIDE ingredient
NCE-1 date: 2025-03-22
Market Authorisation Date: 22 March, 2021
Treatment: NA
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
ZEGALOGUE family patents
5
United States
3
Japan
2
Denmark
2
Korea, Republic of
2
China
2
European Union
1
Israel
1
South Africa
1
Mexico
1
Australia
1
Hong Kong
1
Philippines
1
Singapore
1
Argentina
1
Brazil
1
Malaysia
1
Spain
1
Poland
1
Taiwan, Province of China
1
India
1
Ukraine
1
EA
1
Canada
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic